K. Lang

Women Administered Standard Dose Imatinib for Chronic Myeloid Leukemia Have Higher Dose-Adjusted Plasma Imatinib and Norimatinib Concentrations Than Men

G. Mufti, R. Flanagan, R. Ireland, 2017, Therapeutic drug monitoring.

Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom

J. Cappelleri, C. Mamolo, Priyanka Mehta, 2018, Health and Quality of Life Outcomes.

A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia.

J. Cappelleri, K. Fahrbach, M. Orme, 2019, Future oncology.

BLOODPAC: Collaborating to chart a path towards blood‐based screening for early cancer detection

H. Scher, C. Clarke, P. Kuhn, 2022, Clinical and translational science.

Abstract PS18-15: Real-world clinical-genomic data identifies the ESR1 clonal and subclonal circulating tumor DNA (ctDNA) landscape and provides insight into clinical outcomes

S. Fairclough, V. Raymond, Naveen Kumar, 2021 .

Real-World Treatment Patterns in Patients With HER2-Amplified Metastatic Colorectal Cancer: A Clinical-Genomic Database Study.

T. Bekaii-Saab, J. Strickler, L. Hsu, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.